Systemic α-MSH suppresses LPS fever via central melanocortin receptors independently of its suppression of corticosterone and IL-6 release

被引:57
作者
Huang, QH
Hruby, VJ
Tatro, JB
机构
[1] Tufts Univ, Sch Med, Dept Med, Div Endocrinol Diabet Metab & Mol Med, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, Tupper Res Inst, Boston, MA 02111 USA
[3] Tufts Univ, New England Med Ctr Hosp, Boston, MA 02111 USA
[4] Univ Arizona, Dept Chem, Tucson, AZ 85721 USA
关键词
lipopolysaccharide; adrenocorticotropic hormone; interleukin-6; rat; SHU-9119; alpha-melanocyte-stimulating hormone;
D O I
10.1152/ajpregu.1998.275.2.R524
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Systemically administered alpha-melanocyte-stimulating hormone (alpha-MSH) inhibits endotoxin (lipopolysaccharide; LPS)- or interleukin (IL)-1-induced fever and adrenocortical activation, but the sites of these actions and the mechanisms involved are unknown. The aims of this study were, first, to determine whether melanocortin receptors (MCR) located within the central nervous system mediate the suppressive effects of peripherally administered alpha-MSH on LPS-induced fever and activation of the pituitary-adrenal axis and, second, to determine whether systemic alpha-MSH suppresses the LPS-induced rise in plasma IL-6 levels, potentially contributing to its antipyretic effect. Male rats received Escherichia coli LPS (25 mu g/kg ip). Core body temperatures (T-b) were determined hourly by radiotelemetry (0-8 h), and blood was withdrawn via venous catheters for plasma hormone immunoassays (0-2 h) and IL-6 bioassay (0-8 h). alpha-MSH (100 mu g/kg ip) completely prevented the onset of LPS-induced fever during the first 3-4 h after LPS and suppressed fever throughout the next 4 h but did not affect T-b in afebrile rats treated with intraperitoneal saline rather than LPS. Intraperitoneal alpha-MSH also suppressed the LPS-induced rise in plasma IL-6, ACTH, and corticosterone (CS) levels. Intracerebroventricular injection of SHU-9119, a potent melanocortin-4 receptor (MC4-R)/MC3-R antagonist, completely blocked the antipyretic effect of intraperitoneal alpha-MSH during the first 4 h after LPS but had no effect on alpha-MSH-induced suppression of LPS-stimulated plasma IL-6 and CS levels. Taken together, the results indicate that the antipyretic effect of peripherally administered alpha-MSH during the early phase of fever is mediated by MCR within the brain. In contrast, the inhibition of LPS-induced increases in plasma CS and IL-6 levels by intraperitoneal alpha-MSH appears to be mediated by a different mechanism(s), and these effects do not contribute to its antipyretic action.
引用
收藏
页码:R524 / R530
页数:7
相关论文
共 30 条